The Rising Cost of AI Enterprises Face a Tokens or Humans Dilemma as Budgets Burn Through BRKRP Q1 2026 Earnings Preferred Stock EPS Surges Past Expectations with 30 Beat Citi Initiates Cytokinetics as Top Pick Among SmalltoMid Cap Biotech Stocks Sees Upside from Myqorzo Launch and Phase 3 Data